Literature DB >> 12032324

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Eddie C Y Wang1, Brian McSharry, Christelle Retiere, Peter Tomasec, Sheila Williams, Leszek K Borysiewicz, Veronique M Braud, Gavin W G Wilkinson.   

Abstract

Human cytomegalovirus (HCMV) exploits a range of strategies to evade and modulate the immune response. Its capacity to down-regulate MHC I expression was anticipated to render infected cells vulnerable to natural killer (NK) attack. Kinetic analysis revealed that during productive infection, HCMV strain AD169 first enhanced and then inhibited lysis of primary skin fibroblasts by a CD94/NKG2A(+)NKG2D(+)ILT2(+) NK line. The inhibition of cytotoxicity against strain AD169-infected fibroblasts was abolished by prior treatment of targets or effectors with anti-MHC I and anti-CD94 monoclonal antibodies, respectively, implying a CD94/HLA-E-dependent mechanism. An HCMV strain AD169, UL40 deletion mutant could not inhibit CD94/NKG2A(+) NK killing against skin fibroblasts. The contribution of UL40 to evasion of primary NK cells then was tested in a system where targets and effectors were MHC-matched. Primary NK cells activated with IFNalpha as well as cultured primary NK cell lines showed increased killing against DeltaUL40-infected fibroblasts compared with AD169-infected targets. This effect was abrogated by depletion of CD94(+) cells. These findings demonstrate that HCMV encodes a mechanism of evasion specifically targeted against a proportion of CD94(+) NK cells and show that this system functions during a productive infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032324      PMCID: PMC124287          DOI: 10.1073/pnas.112680099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  An activating immunoreceptor complex formed by NKG2D and DAP10.

Authors:  J Wu; Y Song; A B Bakker; S Bauer; T Spies; L L Lanier; J H Phillips
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

2.  Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Authors:  C A Benedict; K D Butrovich; N S Lurain; J Corbeil; I Rooney; P Schneider; J Tschopp; C F Ware
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

3.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells.

Authors:  S Sivori; D Pende; C Bottino; E Marcenaro; A Pessino; R Biassoni; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

4.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

Authors:  H Zhu; J P Cong; G Mamtora; T Gingeras; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.

Authors:  N Lee; D R Goodlett; A Ishitani; H Marquardt; D E Geraghty
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

6.  Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.

Authors:  J M Fletcher; H G Prentice; J E Grundy
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.

Authors:  M Llano; N Lee; F Navarro; P García; J P Albar; D E Geraghty; M López-Botet
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

8.  Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

Authors:  A Pessino; S Sivori; C Bottino; A Malaspina; L Morelli; L Moretta; R Biassoni; A Moretta
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

9.  Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.

Authors:  C C Leong; T L Chapman; P J Bjorkman; D Formankova; E S Mocarski; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Authors:  M Vitale; C Bottino; S Sivori; L Sanseverino; R Castriconi; E Marcenaro; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  50 in total

1.  HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.

Authors:  Gabriella Pietra; Chiara Romagnani; Paola Mazzarino; Michela Falco; Enrico Millo; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 2.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

4.  Genomic location and characterisation of nonclassical MHC class I genes in cattle.

Authors:  James Birch; Gemma Codner; Efrain Guzman; Shirley A Ellis
Journal:  Immunogenetics       Date:  2008-04-23       Impact factor: 2.846

5.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

6.  The cytoplasmic domain of rhesus cytomegalovirus Rh178 interrupts translation of major histocompatibility class I leader peptide-containing proteins prior to translocation.

Authors:  Rebecca Richards; Isabel Scholz; Colin Powers; William R Skach; Klaus Früh
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

7.  Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus.

Authors:  Claire Gealy; Marian Denson; Christine Humphreys; Brian McSharry; Gavin Wilkinson; Richard Caswell
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  Viruses       Date:  2009       Impact factor: 5.048

Review 9.  The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Authors:  Gabriella Pietra; Chiara Romagnani; Claudia Manzini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  J Biomed Biotechnol       Date:  2010-06-22

10.  Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Authors:  Susan L Heatley; Gabriella Pietra; Jie Lin; Jacqueline M L Widjaja; Christopher M Harpur; Sue Lester; Jamie Rossjohn; Jeff Szer; Anthony Schwarer; Kenneth Bradstock; Peter G Bardy; Maria Cristina Mingari; Lorenzo Moretta; Lucy C Sullivan; Andrew G Brooks
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.